Stay updated on Gene Transfer for SMA Type 1 Clinical Trial
Sign up to get notified when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.

Latest updates to the Gene Transfer for SMA Type 1 Clinical Trial page
- Check5 days agoChange DetectedThe page adds recruitment visibility updates and new help sections for joining and understanding the study, while an existing label formatting for Intervention/Treatment changes and a new revision note (v3.6.0) were introduced.SummaryDifference0.5%

- Check12 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, reflecting a software update rather than changes to the study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new 2021 Drug Saf publication citation is added, and the Erratum citation from 2022 is removed. The page revision is updated to v3.5.4.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now includes an additional referenced publication related to onasemnogene abeparvovec in spinal muscular atrophy type 1. The page revision/version label has also been updated from the previous revision number.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded a new bibliographic entry for the Day et al. paper on Onasemnogene Abeparvovec Therapy, including an Erratum, with revision noted as v3.5.2. Removed the older version of the same reference (revision v3.5.0).SummaryDifference0.1%

- Check90 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Gene Transfer for SMA Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.